PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Health & Medicine
Continue reading
Metformin: The age-old elixir of life?
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
The legacy of a girl who inspired a “holy grail” cancer-killing pill
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Endometriosis linked to infection with common bacteria
Sophie Beaumont reports on a newly discovered link between Fusobacterium infection and endometriosis.
FDA approves treatment for menopausal hot flushes
Sophie Beaumont reports on a new non-hormonal drug for hot flushes, recently approved by the US Food and Drug Administration.
When size matters: New research strategies targeting cancer cells
Lola Bell reports on a new study suggesting the size of cancer cells could become a new diagnostic for directing treatment.
WHO finds that 1 in 6 people experience infertility globally
Miya McFarlane outlines the findings of a new report from the World Health Organisation suggesting an urgent need for fertility healthcare.
Restoring gamma oscillations may treat depression
Leah Fogarty reports on a new study that suggests brain waves known as gamma oscillations may be key to treating depression.
Lymphatic vessels shown to exist within bone
Sarya Fidan describes new research from Oxford that reveals the presence of lymphatic vessels in bone, and their role in bone repair.
England on track to be first country to eliminate hepatitis C
England is set to eliminate hepatitis C by 2025, making it the first country in the world to do so, thanks to an antiviral drug deal.